Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schiffer

Showing results (71-80 of 176) with videos related to

Pageof 18
Sort By:
Nature Communications|June 9, 2021
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccinationLaura Matrajt, Julia Eaton, Tiffany Leung, et al.
Viruses|February 8, 2020
Estimating the Risk of Human Herpesvirus 6 and Cytomegalovirus Transmission to Ugandan Infants from Viral Shedding in Saliva by Household ContactsBryan T Mayer, Elizabeth M Krantz, Anna Wald, et al.
Sexually Transmitted Diseases|March 31, 2010
Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Ramzi A Alsallaq, Joshua T Schiffer, Ira M Longini, et al.
Med (New York, N.Y.)|April 26, 2021
Rapid vaccination and partial lockdown minimize 4<sup>th</sup> waves from emerging highly contagious SARS-CoV-2 variantsDaniel B Reeves, Chloe Bracis, David A Swan, et al.
The Journal of Infectious Diseases|February 14, 2015
Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial VaginosisBryan T Mayer, Sujatha Srinivasan, Tina L Fiedler, et al.
The Journal of Pediatrics|December 11, 2014
Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infectionAnn J Melvin, Kathleen M Mohan, Joshua T Schiffer, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2016
Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleasesPavitra Roychoudhury, Harshana S De Silva Feelixge, Harlan L Pietz, et al.
Nature Communications|November 18, 2018
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferationDaniel B Reeves, Elizabeth R Duke, Thor A Wagner, et al.
Plos Computational Biology|April 6, 2022
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV preventionBryan T Mayer, Allan C deCamp, Yunda Huang, et al.
Scientific Reports|June 5, 2021
Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementationAshish Goyal, Daniel B Reeves, Niket Thakkar, et al.
Pageof 18

Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Nature Communications|June 9, 2021
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccinationLaura Matrajt, Julia Eaton, Tiffany Leung, et al.
Viruses|February 8, 2020
Estimating the Risk of Human Herpesvirus 6 and Cytomegalovirus Transmission to Ugandan Infants from Viral Shedding in Saliva by Household ContactsBryan T Mayer, Elizabeth M Krantz, Anna Wald, et al.
Sexually Transmitted Diseases|March 31, 2010
Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Ramzi A Alsallaq, Joshua T Schiffer, Ira M Longini, et al.
Med (New York, N.Y.)|April 26, 2021
Rapid vaccination and partial lockdown minimize 4<sup>th</sup> waves from emerging highly contagious SARS-CoV-2 variantsDaniel B Reeves, Chloe Bracis, David A Swan, et al.
The Journal of Infectious Diseases|February 14, 2015
Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial VaginosisBryan T Mayer, Sujatha Srinivasan, Tina L Fiedler, et al.
The Journal of Pediatrics|December 11, 2014
Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infectionAnn J Melvin, Kathleen M Mohan, Joshua T Schiffer, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2016
Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleasesPavitra Roychoudhury, Harshana S De Silva Feelixge, Harlan L Pietz, et al.
Nature Communications|November 18, 2018
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferationDaniel B Reeves, Elizabeth R Duke, Thor A Wagner, et al.
Plos Computational Biology|April 6, 2022
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV preventionBryan T Mayer, Allan C deCamp, Yunda Huang, et al.
Scientific Reports|June 5, 2021
Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementationAshish Goyal, Daniel B Reeves, Niket Thakkar, et al.
Pageof 18